BANK OF AMERICA CORP /DE/ - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886FAD9. A total of 3 filers reported holding REGENERON PHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q2 2016$8,000
-11.1%
2,0000.0%0.00%
Q1 2016$9,000
-30.8%
2,0000.0%0.00%
Q4 2015$13,000
+18.2%
2,0000.0%0.00%
Q3 2015$11,000
-8.3%
2,0000.0%0.00%
Q2 2015$12,0002,0000.00%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2016
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 10,301,000$44,037,0000.02%
Allianz Asset Management GmbH 220,000$1,025,0000.00%
BANK OF AMERICA CORP /DE/ 2,000$9,0000.00%
View complete list of REGENERON PHARMACEUTICALS shareholders